The law would require Medicare Part D plans to include lower‑cost generics when they are cheaper than brand‑name drugs.

RDCA slams misleading media coverage on generics, calls for regulatory context: Peethaambaran Kunnathoor, Chennai Saturday, ...

Industry analysts and economists warn Trump's prescription drug policy is making it harder for smaller firms to compete while ...

James Carville, a longtime adviser to former President Bill Clinton, coined the phrase, “It’s the economy, stupid,” to capture voters’ anxiety about their personal finances, jobs, and the cost of ...

MSN Laboratories launches Semabest, a cost-effective semaglutide generic, enhancing access to diabetes treatment in India.

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for essential medicines. Soaring raw material costs, particularly ...

The drug’s distributor, Viatris, said it was recalling one lot containing 51 bottles of 3 milligram extended release tablets.

Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for Glycerol ...

Ultimate disposition showed 54% approval (7% same-day; 47% after multiple days) and 46% denial, with 27% rejected within 1 ...

The Food and Drug Administration has announced a voluntary recall of select lots of Xanax. The incredibly popular ...

Lupin said that its wholly owned subsidiary, Lupin Pharmaceuticals Inc., has entered into a settlement agreement with Humana Inc. in connection with civil antitrust litigation in the United States.